New Enterprise Associates 15, L.P. Aveo Pharmaceuticals, Inc. (AVEO) insider trading activity

New Enterprise Associates 15, L.P. is > 10% Shareholder of AVEO PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of AVEO, which is worth approximately $0. The most recent transaction as insider was on Oct 19, 2022, when has been sold 3,952,957 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

New Enterprise Associates 15, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 19 2022	SELL Other acquisition or disposition	-	3,952,957 Reduced 100.0%	0 Common Stock
Oct 19 2022	BUY Other acquisition or disposition	-	3,952,957 Added 50.0%	3,952,957 Common Stock

Also insider at

EAR

Eargo, Inc. Healthcare

> 10% Shareholder

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

Desktop Metal, Inc. Technology

> 10% Shareholder

BHG

Bright Health Group Inc. Healthcare

HOOD

Robinhood Markets, Inc. Technology

Director

ACLX

Arcellx, Inc. Healthcare

> 10% Shareholder

IONQ

IonQ, Inc. Technology

> 10% Shareholder

BGRY

Berkshire Grey, Inc. Industrials

> 10% Shareholder

NEA